The People's Insurance Co (Group) of China (STU:PIR) Research & Development: €0 Mil (TTM As of Dec. 2025)


STU:PIR The People's Insurance Co (Group) of China Ltd STU:PIR
78 GF Score
Price €0.53
GF Value €0.47
! 2 Warning Signs
View Full Analysis

What is The People's Insurance Co (Group) of China Research & Development?

The People's Insurance Co (Group) of China STU:PIR 78 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates STU:PIR with a GF Score™ of 78/100 and a GF Value™ of €0.47. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. The People's Insurance Co (Group) of China's Research & Development for the three months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

The People's Insurance Co (Group) of China  (STU:PIR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The People's Insurance Co (Group) of China Research & Development Related Terms

The People's Insurance Co (Group) of China Research & Development Historical Data

* Premium members only.

The historical data trend for The People's Insurance Co (Group) of China's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The People's Insurance Co (Group) of China Research & Development Chart

The People's Insurance Co (Group) of China Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

The People's Insurance Co (Group) of China Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:PIR
78GF Score
The People's Insurance Co (Group) of China Ltd STU:PIR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The People's Insurance Co (Group) of China Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
The People's Insurance Co (Group) of China (STU:PIR) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on The People's Insurance Co (Group) of China and its competitors.
Is The People's Insurance Co (Group) of China's Research & Development too high?
The People's Insurance Co (Group) of China's current Research & Development is €0 Mil. Overall, The People's Insurance Co (Group) of China has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does The People's Insurance Co (Group) of China's Research & Development compare to CB and PGR?
The People's Insurance Co (Group) of China's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on The People's Insurance Co (Group) of China and its competitors. The People's Insurance Co (Group) of China's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The People's Insurance Co (Group) of China stock overvalued right now?
The People's Insurance Co (Group) of China (STU:PIR) has a current Research & Development of €0 Mil. The stock's GF Value™ is €0.47, compared to a current price of €0.53 — trading 12.8% above its estimated fair value. The current Research & Development is €0 Mil. The People's Insurance Co (Group) of China's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For The People's Insurance Co (Group) of China (STU:PIR), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The People's Insurance Co (Group) of China (STU:PIR) Overvalued in 2026?

Based on GuruFocus' analysis, The People's Insurance Co (Group) of China stock appears to be overvalued. The current stock price of €0.53 is trading 12.8% above its estimated GF Value™ of €0.47.

Key valuation signals for STU:PIR:

  • Research & Development: €0 Mil
  • GF Value™: €0.47 vs. price of €0.53 (12.8% above fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the STU:PIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The People's Insurance Co (Group) of China Business Description

Address No. 88, West Chang’an Avenue, 1st-13th Floor, Xi Cheng District, Beijing, CHN, 100031
PICC Group, headquartered in Beijing, is the largest state-owned insurance group in China. It holds a 69% stake in PICC Property and Casualty, an 80% stake in PICC Life, and a 69% stake in PICC Health Insurance. The P&C subsidiary is the largest nonlife insurer in the country, with approximately one-third of market share. The life insurance and health insurance subsidiaries hold less than 5% market share. The Ministry of Finance is the largest shareholder with a 61% stake, while China's Social Security Fund is the second-largest shareholder, holding nearly 13%.
78GF Score

Get the complete analysis for STU:PIR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.53
Price
€0.47
GF Value